Statins for age-related macular degeneration

Cochrane Database of Systematic Reviews

Volumn , Issue 1, 2008, Pages

  Gehlbach, Peter ^a   Li, T ^b   Hatef, E ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MINERAL; PEGAPTANIB; RANIBIZUMAB; VITAMIN;

CLINICAL TRIAL; COST BENEFIT ANALYSIS; DATA ANALYSIS; DATA EXTRACTION; DISEASE COURSE; DRUG EFFICACY; DRUG MECHANISM; HUMAN; INFORMATION PROCESSING; LASER COAGULATION; PHOTODYNAMIC THERAPY; QUALITY CONTROL; QUALITY OF LIFE; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SENSITIVITY ANALYSIS; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT; VITAMIN SUPPLEMENTATION;

EID: 44949123631     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006927     Document Type: Review

References (31)

1. AAO 2006 American Academy of Ophthalmology Retina Panel. Age-Related Macular Degeneration Limited Revision Preferred Practice Pattern. American Academy of Ophthalmology 2006.
2. AREDS 2001 Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology 2001;119(10):1417-36.
3. Congdon 2003 Congdon NG, Friedman DS, Lietman T. Important causes of visual impairment in the world today. The Journal of the Amedican Medical Association 2003;290(15):2057-60.
4. Deeks 2006 Deeks JJ, Higgins JPT, Altman DG, editors. Section 8. Analysing and presenting data. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. Chichester, UK: John Wiley & Sons, Ltd, updated September 2006.
5. Evans 2006 Evans JR. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration. Cochrane Database of Systematic Reviews 2006, Issue 2.Art. No.: CD000254. DOI:10.1002/14651858.CD000254.pub2.
6. Evans 2008 Evans JR. Antioxidant vitamin and mineral supplementation for preventing age-related macular degeneration. Cochrane Database of Systematic Reviews 2008, Issue 1.Art. No.: CD000253. DOI:10.1002/14651858.CD000253.
7. Friedman 2004 Friedman E. Update of the vascular model of AMD. British Journal of Ophthalmology 2004 Feb;88(2):161-3.
8. Glanville 2006 Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
9. Gurne 1991 Gurne DH, Tso MO, Edward DP, Ripp H. Antiretinal antibodies in serum of patients with age-related macular degeneration. Ophthalmology 1991;98(5):602-7.
10. Guymer 2005 Guymer RH, Chiu AW, Lim L, Baird PN. HMG CoA reductase inhibitors (statins): do they have a role in age-related macular degeneration?. Survey of Ophthalmology 2005;50(2):194-206.
11. Hall 2001 Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN. Risk of macular degeneration in users of statins: cross sectional study. British Medical Journal 2001 Aug 18;323(7309):375-6.
12. Higgins 2006 Higgins JPT, Green S, editors. Section 6. Assessment of study quality. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6. Chichester, UK: John Wiley & Sons, Ltd, updated September 2006.
13. Klein 1992 Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99(6):933-43.
14. Klein 2001 Klein R, Klein BE, Jensen SC, Cruickshanks KJ, Lee KE, Danforth LG, et al.Medication use and the 5-year incidence of early age-related maculopathy: The Beaver Dam Eye Study. Archives of Ophthalmology 2001;119(9):1354-9.
15. Klein 2002 Klein R, Klein BE, Tomany SC, Meuer SM, Huang GH. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Ophthalmology 2002;109(10):1767-79.
16. Klein 2007a Klein R, Deng Y, Klein BE, Hyman L, Seddon J, Frank RN, et al.Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women's Health Initiative Sight Exam ancillary study. Ophthalmology 2007;143(3):473-83.
17. Klein 2007b Klein R, Knudtson MD, Klein BE. Statin use and the five-year incidence and progression of age-related macular degeneration. American Journal of Ophthalmology 2007;144(1):1-6.
18. McGwin 2003 McGwin G Jr, Owsley C, Curcio CA, Crain RJ. The association between statin use and age related maculopathy. British Journal of Ophthalmology 2003;87(9):1121-5.
19. McGwin 2006 McGwin G, Modjarrad K, Hall TA, Xie A, Owsley C. 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors and the presence of age-related macular degeneration in the Cardiovascular Health Study. Archives of Ophthalmology 2006;124(1):33-7.
20. Mitchell 1995 Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102(10):1450-60.
21. MPS 1991 Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Five-year results from randomized clinical trials. Archives of Ophthalmology 1991;109(8):1109-14.
22. MPS 1994 Macular Photocoagulation Study Group. Laser photocoagulation for juxtafoveal choroidal neovascularization. Five-year results from randomized clinical trials. Archives of Ophthalmology 1994;112(4):500-9.
23. Penfold 2001 Penfold PL, Madigan MC, Gillies MC, Provis JM. Immunological and aetiological aspects of macular degeneration. Progress in Retinal and Eye Research 2001;20(3):385-414.
24. Sagara 2007 Sagara N, Kawaji T, Takano A, Inomata Y, Inatani M, Fukushima M, et al.Effect of pitavastatin on experimental choroidal neovascularization in rats. Experimental Eye Research 2007;84(6):1074-80.
25. Smeeth 2005 Smeeth L, Cook C, Chakravarthy U, Hubbard R, Fletcher AE. A case control study of age related macular degeneration and use of statins. British Journal of Ophthalmology 2005;89(9):1171-5.
26. Smith 2001 Smith W, Assink J, Klein R, Mitchell P, Klaver CC, Klein BE, et al.Risk factors for age-related macular degeneration, Pooled findings from three continents. Ophthalmology 2001;108(4):697-704.
27. Spaide 1999 Spaide RF, Ho-Spaide WC, Browne RW, Armstrong D. Characterization of peroxidized lipids in Bruch's membrane. Retina 1999;19(2):141-147.
28. Tan 2007 Tan JS, Mitchell P, Rochtchina E, Wang JJ. Statins and the long-term risk of incident age-related macular degeneration: The Blue Mountains Eye Study. American Journal of Ophthalmology 2007;143(4):685-7.
29. van Leeuwen 2003 van Leeuwen R, Vingerling JR, Hofman A, de Jong PT, Stricker BH. Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement. British Medical Journal 2003;326(7383):255-6.
30. Virgili 2007 Virgili G, Bini A. Laser photocoagulation for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 3.Art. No.: CD004763. DOI:10.1002/14651858.CD004763. pub2.
31. Wormald 2007 Wormald R, Evans J, Smeeth L, Henshaw K. Photodynamic therapy for neovascular age-related macular degeneration. Cochrane Database of Systematic Reviews 2007, Issue 3.Art. No.: CD002030. DOI:10.1002/ 14651858.CD002030.pub3.